BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 11060067)

  • 1. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
    Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
    J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
    Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
    J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa.
    Mauclère P; Le Hesran JY; Mahieux R; Salla R; Mfoupouendoun J; Abada ET; Millan J; de Thé G; Gessain A
    J Infect Dis; 1997 Aug; 176(2):505-9. PubMed ID: 9237719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
    Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
    Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides.
    Goubau P; Desmyter J; Swanson P; Reynders M; Shih J; Surmont I; Kazadi K; Lee H
    J Med Virol; 1993 Jan; 39(1):28-32. PubMed ID: 8093712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
    Lal RB; Brodine SK; Coligan JE; Roberts CR
    J Med Virol; 1991 Dec; 35(4):232-6. PubMed ID: 1687064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
    Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
    Costa JM; Segurado AC
    J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians.
    Lal RB; Rudolph DL; Nerurkar VR; Yanagihara R
    Viral Immunol; 1992; 5(4):265-72. PubMed ID: 1282011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH; McAlpine L; Mortimer PP
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.
    Filippone C; Bassot S; Betsem E; Tortevoye P; Guillotte M; Mercereau-Puijalon O; Plancoulaine S; Calattini S; Gessain A
    J Clin Microbiol; 2012 May; 50(5):1663-72. PubMed ID: 22403426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of a human T-lymphotropic virus type I gag protein epitope that cross-reacts with anti-Plasmodium falciparum antibodies.
    Porter KR; Anthony RL; Solihin A; Hayes CG
    J Med Virol; 1995 Apr; 45(4):469-74. PubMed ID: 7545215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
    Abrams A; Akahata Y; Jacobson S
    Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
    J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.